Correlation Between Citigroup and XBiotech
Can any of the company-specific risk be diversified away by investing in both Citigroup and XBiotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and XBiotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and XBiotech, you can compare the effects of market volatilities on Citigroup and XBiotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of XBiotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and XBiotech.
Diversification Opportunities for Citigroup and XBiotech
Excellent diversification
The 3 months correlation between Citigroup and XBiotech is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and XBiotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XBiotech and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with XBiotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XBiotech has no effect on the direction of Citigroup i.e., Citigroup and XBiotech go up and down completely randomly.
Pair Corralation between Citigroup and XBiotech
Taking into account the 90-day investment horizon Citigroup is expected to generate 0.34 times more return on investment than XBiotech. However, Citigroup is 2.97 times less risky than XBiotech. It trades about 0.08 of its potential returns per unit of risk. XBiotech is currently generating about -0.05 per unit of risk. If you would invest 9,366 in Citigroup on August 18, 2025 and sell it today you would earn a total of 664.00 from holding Citigroup or generate 7.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Citigroup vs. XBiotech
Performance |
| Timeline |
| Citigroup |
| XBiotech |
Citigroup and XBiotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Citigroup and XBiotech
The main advantage of trading using opposite Citigroup and XBiotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, XBiotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XBiotech will offset losses from the drop in XBiotech's long position.| Citigroup vs. Mitsubishi UFJ Financial | Citigroup vs. Royal Bank of | Citigroup vs. Wells Fargo | Citigroup vs. Bank of America |
| XBiotech vs. Nutriband | XBiotech vs. Adagene | XBiotech vs. Fortress Biotech | XBiotech vs. Tscan Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |